Simpson Manufacturing Co., Inc. (SSD)
NYSE: SSD · Real-Time Price · USD
181.31
-0.72 (-0.40%)
Aug 8, 2025, 4:00 PM - Market closed
Inozyme Pharma Stock Forecast
Stock Price Forecast
The 2 analysts that cover Inozyme Pharma stock have a consensus rating of "Buy" and an average price target of $188.5, which forecasts a 3.97% increase in the stock price over the next year. The lowest target is $185 and the highest is $192.
Price Target: $188.5 (+3.97%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inozyme Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Hold Maintains $180 → $185 | Hold | Maintains | $180 → $185 | +2.04% | Jul 29, 2025 |
| DA Davidson | DA Davidson | Hold Maintains $195 → $185 | Hold | Maintains | $195 → $185 | +2.04% | Mar 11, 2025 |
| Baird | Baird | Buy Maintains $196 → $192 | Buy | Maintains | $196 → $192 | +5.90% | Feb 11, 2025 |
| Baird | Baird | Buy Maintains $202 → $218 | Buy | Maintains | $202 → $218 | +20.24% | Oct 21, 2024 |
| Baird | Baird | Buy Maintains $215 → $208 | Buy | Maintains | $215 → $208 | +14.72% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
2.31B
from 2.23B
Increased by 3.62%
Revenue Next Year
2.46B
from 2.31B
Increased by 6.14%
EPS This Year
8.18
from 7.60
Increased by 7.64%
EPS Next Year
8.97
from 8.18
Increased by 9.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 2.4B | 2.6B |
| Avg | 2.3B | 2.5B |
| Low | 2.2B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 8.1% | 12.8% |
| Avg | 3.6% | 6.1% |
| Low | 0.0% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 8.61 | 9.66 |
| Avg | 8.18 | 8.97 |
| Low | 7.84 | 8.39 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 13.3% | 18.1% |
| Avg | 7.6% | 9.7% |
| Low | 3.2% | 2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.